4.69
4.09%
-0.20
After Hours:
4.51
-0.18
-3.84%
Mustang Bio Inc Stock (MBIO) Latest News
Mustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News Summary - Benzinga
Mustang Bio stock plunges to 52-week low of $4 - Investing.com
Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat
Mustang Bio Inc. Appoints Michael J. Zelefsky as Director -June 13, 2017 at 04:02 pm EDT - Marketscreener.com
Mustang Bio, Inc. Announces Management Changes -April 24, 2017 at 08:00 am EDT - Marketscreener.com
Mustang Bio, Inc. Appoints Peter Carney as the Interim Chief Accounting Officer -December 12, 2023 at 06:23 am EST - Marketscreener.com
Mustang Bio, Inc. Terminates Exclusive License Agreement with Regents of the University of California - Marketscreener.com
UBriGene Biosciences Inc. completed the acquisition of Worcester manufacturing facility of Mustang Bio, Inc. - Marketscreener.com
Mustang Bio, Inc. Announces CFO Changes -November 15, 2024 at 04:50 pm EST - Marketscreener.com
Mustang Bio stock plunges to 52-week low of $0.13 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $0.13 - Investing.com
Mustang Bio Announces Reverse Stock Split - GlobeNewswire
Mustang Bio announces 1-for-50 reverse stock split By Investing.com - Investing.com Nigeria
Dow Gains Over 200 Points; Signet Jewelers Shares Plunge - Benzinga
Mustang Bio Lauds New Stock Split - Baystreet.ca
Mustang Bio announces 1-for-50 reverse stock split - Investing.com India
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December - Benzinga
Mustang Bio secures shareholder nod for major stock issuance By Investing.com - Investing.com Nigeria
Mustang Bio secures shareholder nod for major stock issuance - Investing.com India
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off - MSN
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn
Wall Street Today: US stocks open higher after markets reopen post New Year; Tesla shares down 7% on low delivery data | Stock Market News - Mint
Mustang Bio files to sell 34.77M shares of common stock for holders - MSN
Mustang Bio Inc Still Hasn’t Convinced Analysts? - Stocks Register
Fortress Biotech subsidiary gains FDA approval for cSCC therapy - Investing.com
Likelihood of Approval and Phase Transition Success Rate ModelMB-108 in Recurrent Malignant Glioma - GlobalData
Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
Mustang Bio faces delisting, appoints new interim CFO - Investing.com
Mustang Bio's Interim CFO Resigns After 10 Months - MarketWatch
Mustang Bio Faces Nasdaq Delisting and Leadership Changes - TipRanks
Mustang Bio, Inc. Announces CFO Changes - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc - GuruFocus.com
Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy
Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa
Crude Oil Brent (F) (QAX25) Quote - The Globe and Mail
Mustang Bio gets extension for Nasdaq compliance - Investing.com
Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times
Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan
Virus Therapy Gets Orphan Drug Designation for Glioma Treatment - www.oncnursingnews.com/
Mustang Bio Inc (MBIO) Quarterly 10-Q Report - Quartzy
Mustang Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment - Yahoo Finance
Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail
Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):